Antitumor immunity is initiated by antigen-presenting cells that capture tumor antigens from tumor cells and induce the CD4+ Th-1 cell/CD8+ CTL response, and they produce the antitumor cytokine IFN-γ [21]. The gene discussed is IFNG; the disease is neoplasm.